Susquehanna International Group, LLP Takeda Pharmaceutical CO LTD Transaction History
Susquehanna International Group, LLP
- $568 Billion
- Q1 2025
A detailed history of Susquehanna International Group, LLP transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Susquehanna International Group, LLP holds 47,029 shares of TAK stock, worth $692,266. This represents 0.0% of its overall portfolio holdings.
Number of Shares
47,029
Previous 25,911
81.5%
Holding current value
$692,266
Previous $343,000
103.79%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding TAK
# of Institutions
360Shares Held
67.4MCall Options Held
1.72MPut Options Held
186K-
Capital Research Global Investors Los Angeles, CA13.2MShares$194 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.7MShares$83.9 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY5.32MShares$78.3 Million0.01% of portfolio
-
Brandes Investment Partners, LP La Jolla, CA3.5MShares$51.6 Million0.57% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.43MShares$50.5 Million0.1% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $45.8B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...